Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
January 1st, 2024: Tepezza MDL Shows No Activity in Final Week of 2023 The last week of 2023 saw no activity within the Tepezza hearing loss class action MDL, signaling a period of relative inactivity in the legal proceedings
Lancet 402 , 429431 (2023)
The initial dose is typically 2.5 mg, administered once weekly, allowing the body to adjust before increasing the amount
Mitochondrial diseases
However, definitive evidence from adequately powered human trials demonstrating cognitive benefits is still lacking, and ongoing phase 3 studies are investigating these potential effects
US$ 20.60
US$ 26.43
US$ 26.95
